ArticleTherapeutic advances in hematology2022

Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia.

Anna Maria Frustaci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.